AAAAAA
Results: 1-25/29
Authors:
GARG M
VACEK JL
HARRIS WS
Citation: M. Garg et al., LIPOPROTEIN(A) AND RESPONSE TO TISSUE-PLASMINOGEN ACTIVATOR IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION, Journal of investigative medicine, 46(3), 1998, pp. 231-231
Authors:
BYBEE KA
OKEEFE JH
HARRIS WS
GARG S
GEORGE SJ
BATEMAN TM
Citation: Ka. Bybee et al., TRIGLYCERIDES AND HDL CHOLESTEROL, BUT NOT LDL CHOLESTEROL, PREDICT HIGH-RISK FOR ISCHEMIC-HEART-DISEASE AS ASSESSED BY SPECT SCINTIGRAPHY, Circulation, 98(17), 1998, pp. 220-220
Authors:
MARTIN G
ADELMAN HM
HARRIS WS
Citation: G. Martin et al., REQUESTING NECROPSIES - NECROPSY RATE WAS INCREASED TO 21-PERCENT IN ONE HOSPITAL, BMJ. British medical journal, 315(7113), 1997, pp. 952-952
Authors:
ZIOGAS GG
THOMAS TR
HARRIS WS
Citation: Gg. Ziogas et al., EXERCISE TRAINING, POSTPRANDIAL HYPERTRIGLYCERIDEMIA, AND LDL SUBFRACTION DISTRIBUTION, Medicine and science in sports and exercise, 29(8), 1997, pp. 986-991
Authors:
HARRIS WS
DUJOVNE CA
WINDSOR SL
GERROND LLC
NEWTON FA
GELFAND RA
Citation: Ws. Harris et al., INHIBITING CHOLESTEROL ABSORPTION WITH CP-88,818 (BETA-TIGOGENIN CELLOBIOSIDE TIQUESIDE) - STUDIES IN NORMAL AND HYPERLIPIDEMIC SUBJECTS, Journal of cardiovascular pharmacology, 30(1), 1997, pp. 55-60
Authors:
THOMAS TR
ZIOGAS G
HARRIS WS
Citation: Tr. Thomas et al., INFLUENCE OF FITNESS STATUS ON VERY-LOW-DENSITY LIPOPROTEIN SUBFRACTIONS AND LIPOPROTEIN(A) IN MEN AND WOMEN, Metabolism, clinical and experimental, 46(10), 1997, pp. 1178-1183
Authors:
HARRIS WS
HUSTVEDT BE
HAGEN E
GREEN MH
LU GP
DREVON CA
Citation: Ws. Harris et al., N-3 FATTY-ACIDS AND CHYLOMICRON METABOLISM IN THE RAT, Journal of lipid research, 38(3), 1997, pp. 503-515
Authors:
HARRIS WS
SHACHTER NS
OSMUNDSEN K
GINSBERG HN
Citation: Ws. Harris et al., LONG-TERM EFFECTS OF LOW-DOSE OMACOR(R) IN PATIENTS WITH SEVERE HYPERTRIGLYCERIDEMIA, Atherosclerosis, 134(1-2), 1997, pp. 124-124
Authors:
HARRIS WS
NGO KDT
Citation: Ws. Harris et Kdt. Ngo, POWER SWITCHED-CAPACITOR DC-DC CONVERTER - ANALYSIS AND DESIGN, IEEE transactions on aerospace and electronic systems, 33(2), 1997, pp. 386-395
Authors:
HARRIS WS
WINDSOR SL
NEWTON FA
GELFAND RA
Citation: Ws. Harris et al., INHIBITION OF CHOLESTEROL ABSORPTION WITH CP-148,623 LOWERS SERUM-CHOLESTEROL IN HUMANS, Clinical pharmacology and therapeutics, 61(3), 1997, pp. 385-389
Authors:
HARRIS WS
LU GP
RAMBJOR GS
WALEN AI
ONTKO JA
CHENG Q
WINDSOR SL
Citation: Ws. Harris et al., INFLUENCE OF N-3 FATTY-ACID SUPPLEMENTATION ON THE ENDOGENOUS ACTIVITIES OF PLASMA LIPASES, The American journal of clinical nutrition, 66(2), 1997, pp. 254-260
Authors:
HARRIS WS
Citation: Ws. Harris, N-3 FATTY-ACIDS AND SERUM-LIPOPROTEINS - ANIMAL STUDIES, The American journal of clinical nutrition, 65(5), 1997, pp. 1611-1616
Authors:
HARRIS WS
Citation: Ws. Harris, N-3 FATTY-ACIDS AND SERUM-LIPOPROTEINS - HUMAN STUDIES, The American journal of clinical nutrition, 65(5), 1997, pp. 1645-1654
Authors:
HARRIS WS
RAMBJOR GS
WINDSOR SL
DIEDERICH D
Citation: Ws. Harris et al., N-3 FATTY-ACIDS AND URINARY-EXCRETION OF NITRIC-OXIDE METABOLITES IN HUMANS, The American journal of clinical nutrition, 65(2), 1997, pp. 459-464
Authors:
OKEEFE JH
NELSON J
HARRIS WS
Citation: Jh. Okeefe et al., LIFE-STYLE CHANGE FOR CORONARY-ARTERY DISEASE - WHAT TO TELL PATIENTS, Postgraduate medicine, 99(2), 1996, pp. 89
Authors:
RAMBJOR GS
WALEN AI
WINDSOR SL
HARRIS WS
Citation: Gs. Rambjor et al., EICOSAPENTAENOIC ACID IS PRIMARILY RESPONSIBLE FOR HYPOTRIGLYCERIDEMIC EFFECT OF FISH-OIL IN HUMANS, Lipids, 31, 1996, pp. 45-49
Authors:
HARRIS WS
Citation: Ws. Harris, N-3 FATTY-ACIDS AND LIPOPROTEINS - COMPARISON OF RESULTS FROM HUMAN AND ANIMAL STUDIES, Lipids, 31(3), 1996, pp. 243-252
Authors:
HARRIS WS
HUSTVEDT BE
HAGEN E
GREEN MH
DREVON CA
Citation: Ws. Harris et al., OMEGA-3 FATTY ADDS ENHANCE CHYLOMICRON LIPOLYSIS IN THE RAT, Circulation, 92(8), 1995, pp. 1675-1675
Authors:
OKEEFE JH
HARRIS WS
COWAN N
Citation: Jh. Okeefe et al., NIACIN AND MAGNESIUM AS ADJUNCTS TO PRAVASTATIN FOR RISK FACTOR CLUSTERING, SMALL DENSE LDL, AND PROLONGED POSTPRANDIAL LIPEMIA, Circulation, 92(8), 1995, pp. 3407-3407
Authors:
OKEEFE JH
HARRIS WS
NELSON J
WINDSOR SL
Citation: Jh. Okeefe et al., EFFECTS OF PRAVASTATIN WITH NIACIN OR MAGNESIUM ON LIPID-LEVELS AND POSTPRANDIAL LIPEMIA, The American journal of cardiology, 76(7), 1995, pp. 480-484
Authors:
SIMOPOULOS AP
KOLETZKO B
ANDERSON RE
HORNSTRA G
MENSINK RP
WEKSLER BB
HARRIS WS
DECATERINA R
MUGGLI R
SPRECHER H
Citation: Ap. Simopoulos et al., THE 1ST CONGRESS OF THE AL-SOCIETY-FOR-THE-STUDY-OF-FATTY-ACIDS-AND-LIPIDS (ISSFAL) - FATTY-ACIDS AND LIPIDS FROM CELL BIOLOGY TO HUMAN-DISEASE, Journal of lipid research, 35(1), 1994, pp. 169-173
Authors:
ELSHIEKH RA
GERROND LLC
HARRIS WS
DUJOVNE CA
Citation: Ra. Elshiekh et al., BENEFITS OF ESTROGEN-REPLACEMENT THERAPY ON SERUM-LIPOPROTEINS WITH OR WITHOUT CONCURRENT LIPID-REGULATING DRUGS, Circulation, 90(4), 1994, pp. 460-460
Authors:
ELSHIEKH RA
GERROND LLC
HARRIS WS
DUJOVNE CA
Citation: Ra. Elshiekh et al., BENEFITS OF ESTROGEN-REPLACEMENT THERAPY ON SERUM-LIPOPROTEINS WITH OR WITHOUT CONCURRENT LIPID-REGULATING DRUGS, Circulation, 90(4), 1994, pp. 460-460
Authors:
DUJOVNE CA
HARRIS WS
GERROND LLC
FAN JY
MUZIO F
Citation: Ca. Dujovne et al., COMPARISON OF EFFECTS OF PROBUCOL VERSUS VITAMIN-E ON EX-VIVO OXIDATION SUSCEPTIBILITY OF LIPOPROTEINS IN HYPERLIPOPROTEINEMIA, The American journal of cardiology, 74(1), 1994, pp. 38-42
Authors:
HARRIS WS
WINDSOR SL
CASPERMEYER JJ
Citation: Ws. Harris et al., MODIFICATION OF LIPID-RELATED ATHEROSCLEROSIS RISK-FACTORS BY OMEGA-3-FATTY-ACID ETHYL-ESTERS IN HYPERTRIGLYCERIDEMIC PATIENTS, Journal of nutritional biochemistry, 4(12), 1993, pp. 706-712